Broker Ratings

Waters Corporation Share Price Target ‘$324.93’, now .6% Upside Potential

Waters Corporation which can be found using ticker (WAT) have now 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between $350.00 and $300.00 with the average share target price sitting at $324.93. (at the time of writing). Now with the previous closing price of $322.87 and the analysts are correct then there would likely be a percentage uptick in value of .6%. The 50 day MA is $316.25 and the 200 day MA is $280.65. The market capitalization for the company is 19.23B. The stock price for the company is currently $325.21 USD

The potential market cap would be $19,351,374,801 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 30.03, revenue per share of $50.04 and a 13.84% return on assets.

Waters Corporation is a specialty measurement company. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments. The Company’s products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic and government customers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Waters Corporation (WAT) Stock Analysis: Navigating a Healthcare Giant with Strong Revenue Growth and Robust Analyst Support

    Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment narrative with its robust revenue growth and high analyst interest.

    Waters Corporation (WAT) Stock Analysis: A Promising 5.92% Potential Upside for Healthcare Investors

    Waters Corporation (NYSE: WAT), a significant player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market capitalization of $19.92

    Waters Corporation (WAT) Investor Outlook: Exploring a 6% Upside with Robust Revenue Growth

    Waters Corporation (WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing the attention of investors with its innovative solutions and consistent

    Waters Corporation (WAT) Stock Analysis: Navigating a 5.41% Potential Upside in the Healthcare Sector

    Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, stands as a significant entity for investors seeking exposure to analytical workflow

    Waters Corporation (WAT) Stock Analysis: Navigating a 19% Potential Upside with Strategic Insights

    Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector’s diagnostics and research industry, continues to be a focal point for investors seeking opportunities within analytical workflow solutions. With a

    Waters Corporation (WAT)

    ⚠️ No article content returned. You might also enjoy reading  Waters Corporation (WAT): Analyst Ratings Show Potential 28.82% Upside — What Investors Need to Know

      Search

      Search